tag:www.gov.uk,2005:/drug-device-alerts Alerts, recalls and safety information: medicines and medical devices about Dispensing GP practices 2026-05-14T10:59:11+01:00 HM Government tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-fresenius-medical-care-deutschland-gmbh-balance-2-dot-3-percent-glucose-1-dot-25-mmol-slash-l-calcium-solution-for-peritoneal-dialysis-el-26-a-slash-24 2026-05-14T10:59:11+01:00 Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-milpharm-limited-loperamide-hydrochloride-2-mg-orodispersible-tablets-el-26-a-slash-23 2026-05-11T11:02:32+01:00 Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-april-2026 2026-04-29T14:02:41+01:00 MHRA Safety Roundup: April 2026 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-amarox-limited-sertraline-100mg-film-coated-tablets-el-26-a-slash-22 2026-04-28T11:00:11+01:00 Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22 Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-omega-pharma-ltd-napralief-250mg-gastro-resistant-tablets-el-26-a-slash-21 2026-04-24T15:22:20+01:00 Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg… tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-doncaster-pharma-limited-hiprex-1g-tablets-el-26-a-slash-20 2026-04-22T11:00:22+01:00 Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1 g tablets (POM). tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-crescent-pharma-limited-ramipril-10mg-capsules-el-26-a-slash-19 2026-04-20T13:06:09+01:00 Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19 Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-march-2026 2026-03-31T14:01:53+01:00 MHRA Safety Roundup: March 2026 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-bio-products-laboratory-limited-rabies-human-normal-immunoglobulin-500iu-solution-for-injection-el-26-a-slash-18 2026-03-30T10:16:08+01:00 Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18 Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the Human Rabies immunoglobulin. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-sandoz-limited-apixaban-2-dot-5mg-and-5mg-tablets-el-26-a-slash-17 2026-03-26T14:01:58+00:00 Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-quadrant-pharmaceuticals-limited-vesomni-6-mg-slash-0-dot-4-mg-modified-release-tablets-el-26-a-slash-16 2026-03-26T10:02:07+00:00 Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16 Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-regent-medical-limited-slash-molnlycke-health-care-hibiwash-500ml-el-26-a-slash-15 2026-03-23T16:32:53+00:00 Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15 Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-baxter-healthcare-corporation-onkotrone-injection-2-mg-slash-ml-concentrate-for-solution-for-infusion-el-26-a-slash-14 2026-03-17T11:00:03+00:00 Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion, EL(26)A/14 Baxter Healthcare Corporation have informed the MHRA that the Patient Information Leaflet (PIL) packed in specified batches does not contain up to date information relating to the duration of contraception required for femal… tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-rokshaw-limited-trading-as-curaleaf-laboratories-curaleaf-oil-fs-10mg-slash-ml-thc-10mg-slash-ml-cbd-30ml-el-26-a-slash-13 2026-03-12T14:12:08+00:00 Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml), EL(26)A/13 Curaleaf Laboratories are recalling three batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) due to low THC content. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-bayer-plc-various-products-el-26-a-slash-12 2026-03-12T11:00:01+00:00 Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12 Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-crescent-pharma-limited-ramipril-5mg-capsules-el-26-a-slash-11 2026-03-06T15:27:24+00:00 Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11 Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-february-2026 2026-02-25T11:12:50+00:00 MHRA Safety Roundup: February 2026 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-rayner-pharmaceuticals-limited-dropodex-0-dot-1-percent-w-slash-v-eye-drops-solution-el-26-a-slash-10 2026-02-24T13:04:42+00:00 Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution, EL(26)A/10 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-sterling-pharmaceuticals-ltd-specials-manufacturer-ms-32515-kidnaps-melatonin-1mg-in-1ml-oral-solution-el-26-a-slash-09 2026-02-23T10:00:32+00:00 Class 2 Medicines Recall: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution, EL(26)A/09 Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.   tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el-26-a-slash-08 2026-02-17T10:00:42+00:00 Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08 Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-aspar-pharmaceuticals-ltd-ibuprofen-200mg-tablets-ibucalm-200mg-tablets-el-26-a-slash-07 2026-02-04T14:00:44+00:00 Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07 Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-26-a-slash-06 2026-02-03T11:55:55+00:00 Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution, EL(26)A/06 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-accord-healthcare-ltd-carmustine-100-mg-powder-and-solvent-for-concentrate-for-solution-for-infusion-1-vial-100mg-powder-1-vial-of-3-ml-solvent-el-26-a-slash-05 2026-02-02T11:00:19+00:00 Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent), EL(26)A/05 Accord Healthcare limited is recalling a single batch due to an out of specification test result. tag:www.gov.uk,2005:/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr 2026-01-29T12:13:05+00:00 National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRA Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-viatris-products-ltd-arixtra-solution-for-injection-pre-filled-syringes-el-26-a-slash-04 2026-01-28T11:00:06+00:00 Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-january-2026 2026-01-27T14:00:25+00:00 MHRA Safety Roundup: January 2026 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-blumont-pharma-limited-ocumont-eye-ointment-1-percent-w-slash-w-el-26-a-slash-03 2026-01-27T11:00:38+00:00 Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03 Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted… tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-limited-fingolimod-glenmark-0-dot-5-mg-hard-capsules-el-26-a-slash-02 2026-01-21T11:00:19+00:00 Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules, EL(26)A/02 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in… tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-mercury-pharmaceuticals-ltd-paliperidone-mercury-pharma-prolonged-release-suspension-for-injection-in-pre-filled-syringes-el-26-a-slash-01 2026-01-20T13:15:13+00:00 Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes, EL(26)A/01 Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished p… tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-december-2025 2025-12-18T13:55:18+00:00 MHRA Safety Roundup: December 2025 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-activase-pharmaceuticals-limited-prednisolone-5mg-soluble-tablets-el-25-a-slash-54 2025-12-15T14:00:40+00:00 Class 3 Medicines Recall: Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets, EL(25)A/54 Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over time. tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-clarithromycin-500-mg-powder-for-concentrate-for-solution-for-infusion-el-25-a-slash-53 2025-12-11T10:06:54+00:00 Class 2 Medicines Recall: Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion, EL(25)A/53 Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-flamingo-pharma-uk-ltd-amitriptyline-hydrochloride-10mg-25mg-50mg-tablets-el-25-a-slash-52 2025-12-10T14:00:14+00:00 Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets, EL(25)A/52 Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-november-2025 2025-11-27T14:05:40+00:00 MHRA Safety Roundup: November 2025 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-special-concept-development-uk-limited-baclofen-10mg-tablets-el-25-a-slash-51 2025-11-27T13:03:38+00:00 Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets, EL(25)A/51 Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-lexon-uk-ltd-moclobemide-150mg-tablets-el-25-a-slash-50 2025-11-25T14:00:56+00:00 Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets, EL(25)A/50 Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-fingolimod-sun-0-dot-5mg-hard-capsules-el-25-a-slash-49 2025-11-20T11:05:55+00:00 Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Fingolimod SUN 0.5mg hard capsules, EL(25)A/49 Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other batches of Fingolimod SUN 0.5mg ha… tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-atorvastatin-20mg-and-80mg-film-coated-tablets-el-25-a-slash-48 2025-11-11T10:41:57+00:00 Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Atorvastatin 20mg and 80mg Film-coated Tablets, EL(25)A/48 Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-zambon-spa-emylif-50mg-orodispersible-film-el-25-a-slash-47 2025-11-10T10:02:35+00:00 Class 3 Medicines Recall: Zambon SpA, Emylif 50mg orodispersible film, EL(25)A/47 Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing. tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-october-2025 2025-10-28T14:28:26+00:00 MHRA Safety Roundup: October 2025 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-baxter-healthcare-limited-compound-sodium-lactate-solution-for-infusion-bp-hartmanns-solution-for-infusion-in-viaflo-1000ml-el-25-a-slash-46 2025-10-28T10:00:12+00:00 Class 2 Medicines Recall: Baxter Healthcare Limited, Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml, EL(25)A/46 Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL. tag:www.gov.uk,2005:/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-ipratropium-bromide-500-microgram-slash-2ml-nebuliser-solution-el-25-a-slash-45 2025-10-23T13:00:11+01:00 Class 3 Medicines Recall: Accord Healthcare Ltd, Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution, EL(25)A/45 Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. The incorrectly la… tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-relonchem-ltd-various-products-el-25-a-slash-44 2025-10-23T10:59:49+01:00 Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44 Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone… tag:www.gov.uk,2005:/drug-device-alerts/mhra-safety-roundup-september-2025 2025-09-30T13:59:39+01:00 MHRA Safety Roundup: September 2025 Summary of the latest safety advice for medicines and medical device users tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-hikma-farmaceutica-gemcitabine-2g-slash-52-dot-6ml-concentrate-for-solution-for-infusion-el-25-a-slash-43 2025-09-04T11:04:08+01:00 Class 4 Medicines Defect Notification: Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion, EL(25)A/43 Hikma Farmacêutica (Portugal) S.A has informed the MHRA that the Patient Information Leaflet (PIL) contained within batch CB0033 of Gemcitabine 2g/52.6ml concentrate for solution for infusion does not contain the side effect… tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-ipca-laboratories-uk-limited-various-products-el-25-a-slash-42 2025-08-26T13:00:26+01:00 Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42 Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-fexofenadine-hydrochloride-120mg-film-coated-tablets-chanelle-medical-unlimited-company-el-25-a-slash-41 2025-08-21T11:00:22+01:00 Class 4 Medicines Defect Notification: Fexofenadine Hydrochloride 120mg film-coated tablets, Chanelle Medical Unlimited Company, EL(25)A/41 Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on certain batches of Fexofenadine Hydrochloride 120mg film-coated tablets… tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-levetiracetam-accord-100mg-slash-ml-oral-solution-accord-healthcare-limited-uk-el-25-a-slash-40 2025-08-14T11:00:10+01:00 Class 4 Medicines Defect Notification: Levetiracetam Accord 100mg/ml oral solution, Accord Healthcare Limited, UK, EL(25)A/40 Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information. tag:www.gov.uk,2005:/drug-device-alerts/class-4-medicines-defect-notification-topiramate-zydus-pharmaceuticals-uk-20mg-slash-ml-oral-solution-zydus-pharmaceuticals-uk-ltd-el-25-a-slash-39 2025-08-07T10:59:57+01:00 Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd, EL(25)A/39 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution (pack size 150m… tag:www.gov.uk,2005:/drug-device-alerts/class-2-medicines-recall-fucidin-250-mg-tablets-leo-laboratories-ltd-trading-as-leo-pharma-el-25-a-slash-38 2025-08-04T11:00:29+01:00 Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma, EL(25)A/38 LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing.